BNTC — Benitec Biopharma Cashflow Statement
0.000.00%
Last trade - 00:00- $301.79m
- $121.82m
Annual cashflow statement for Benitec Biopharma, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -18.2 | -19.6 | -21.8 | -37.9 | -45.5 |
| Depreciation | |||||
| Non-Cash Items | 1.1 | 0.7 | 1.09 | 17 | 26.8 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.04 | 0.714 | 1.17 | -2.73 | 2.14 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -15.9 | -18 | -19.4 | -23.6 | -16.5 |
| Capital Expenditures | -0.013 | -0.001 | -0.179 | -0.018 | -0.105 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -0.013 | -0.001 | -0.179 | -0.018 | -0.105 |
| Financing Cash Flow Items | 0 | -1.87 | -5.89 | -2.32 | -6.27 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 0 | 16 | 68 | 70.5 | 99 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -15.7 | -1.59 | 48.4 | 46.9 | 82.2 |